What's new in 2018:
* Table 1: meningitis, otitis media, diarrhea, cystitis, UTIs, endocarditis, CAP/HAP/VAP, SBP, appendicitis, pharyngitis, sinusitis, bites, oroya fever/verruga peruna, necrotizing fasciitis, septic shock, thrombophlebitis, botulism
* Table 2: resistant bacteria, including GNB
* Table 3: duration of therapy updated throughout
* Table 4: organism coverage expanded, drugs added (new and old)
* Table 5B: complete update
* Table 9A: recent drugs added
* Table 10A: recent drugs added, e.g., mero-vabor, delaflox, pip-tazo dosing updated, colistin dosing updated, including inhalation (10F)
* Table 11: Isavuconazole indications and dosing
* Table 13: giardia, leishmaniasis, microsporidiosis, malaria, trematodes, cestodes; antiparasitic drug updates (13B, 13D)
* Table 14A: MERS, enterovirus, HSV aseptic meningitis, influenza
* Table 14B: new HCV, CMV drugs
* Table 14C: new ARV drugs
* Table 14F: updated HCV treatment regimens and recommendations
* Table 15A: post-splenectomy bacteremia, asplenia, sickle cell disease
* Table 15B: colorectal, OB-Gyn, ophthalmic and general comments
* Table 16: added peds dosing for additional antibacterials, ARVs, antivirals
* Table 17: renal adjustments for ceftaz-avi, mero-vabor, delaflox
* Table 17C: updated obesity dose adjustments
* Table 17D: NEW list of antibacterials with no need to adjust dose for obesity
* Table 19: comprehensive update to treatment of CAPD peritonitis
* Table 22: added recent drugs |